From: Diabetes experts' reasoning about diabetes prevention studies: a questionnaire survey
Rating the benefit of the intervention as | Estimates of corresponding reductions of late complications | ||||||||
---|---|---|---|---|---|---|---|---|---|
very important | important | not very important | not important at all | >75% | 55–75% | 35–55% | 15–35% | <15% | |
Diabetes prevention | |||||||||
60% diabetes risk reduction (item 1 and 2) | 35/15 (51%) | 19/14 (33%) | 8/1 (9%) | 6/1 (7%) | 7/5 (12%) | 14/8 (23%) | 9/5 (14%) | 11/7 (19%) | 25/6 (32%) |
HbA1c 6.0% versus 6.1% (item 6 and 7) | 1/1 (2%) | 10/7 (17%) | 35/15 (51%) | 22/8 (30%) | 1/1 (2%) | 8/2 (10%) | 14/5 (19%) | 8/5 (13%) | 37/18 (56%) |
0.288 life years gained (item 5) | 3/3 (6%) | 17/9 (27%) | 34/15 (50%) | 13/4 (17%) | n.a. | n.a. | n.a. | n.a. | n.a. |
UKPDS | |||||||||
HbA1c 7.0% versus 7.9% (item 3 and 4) | 22/12 (35%) | 24/15 (40%) | 21/4 (25%) | 0/0 | 2/2 (4%) | 7/4 (12%) | 20/6 (27%) | 22/13 (37%) | 13/6 (20%) |
41 versus 46 out of 100 patients (item 8) | 5/4 (9%) | 36/17 (54%) | 25/10 (36%) | 1/0 (1%) | n.a. | n.a. | n.a. | n.a. | n.a. |